OCCIPITAL NEURALGIA AND HEADACHE - Health Plan of Nevada

significant differences between the 2 treatment groups at any time during the study. Eight weeks after
the initial treatment, 80% of the patients in the RF-group (Group I) and 66,7% of the patients in the
local injection group (Group II) reported a successful treatment in terms of a positive global perceived
effect and/or an visual analogue scale (VAS) reduction of at least 50% compared to the initial VAS.
Sixteen weeks after the initial treatment, the success rate in Group I was 66,7% compared to 55,3% in
Group II. After one year, there was no difference of the success rate in Group I (53,3%) compared to
Group II (50%). A relatively high percentage of patients (33,3%) in both groups were not followed
anymore because of several reasons. The most important reason was the disappointment in the
treatment. (Haspeslagh, 2006)
Stovner et al. (2004) conducted a randomized, sham-controlled study of 12 patients with cervicogenic
headaches. Six patients underwent radiofrequency neurotomy and six patients received sham
treatment. Patients were followed for 2 years. Patients treated with neurotomy were somewhat
improved at 3 months, but later follow-up showed no significant differences between the 2 treatment
groups.
Vanelderen et al. (2010) reported on the results of a prospective trial with 6 months of follow-up in
which pulsed radiofrequency treatment of the greater and/or lesser occipital nerve was used to treat
occipital neuralgia in 19 patients. Patients presenting with clinical findings suggestive of occipital
neuralgia and a positive test block of the occipital nerves with 2 mL of local anesthetic underwent a
pulsed radiofrequency procedure of the culprit nerves. Approximately 52.6% of patients reported a
score of 6 (pain improved substantially) or higher on the Likert scale after 6 months. No complications
were reported. The investigators concluded that pulsed radiofrequency treatment of the greater and/or
lesser occipital nerve is a promising treatment of occipital neuralgia. This study warrants further
placebo-controlled trials.
Halim et al. (2010) conducted a retrospective study that included 86 patients who had undergone
lateral C1-2 joint pulsed radiofrequency application, for cervicogenic headache in a single pain center
from March 2007 to December 2008. The percentage of patients who had >or=50% pain relief at 2
months, 6 months, and 1 year were 50% (43/86), 50% (43/86), and 44.2% (38/86), respectively. Longterm
pain relief at 6 months and 1 year were predicted reliably by >or=50% pain relief at 2 months.
Apart from 1 patient that complained of increased severity of occipital headache lasting several hours,
there were no other reported complications. The lack of a control group limits the validity of the results
of this study.
In a clinical audit of 18 chronic cervical pain patients treated with pulsed radiofrequency, satisfactory
pain relief of at least 50% was achieved in 72% of the patients at 8 weeks (Van Zundert, 2003). Thirtythree
percent of the patients continued with good treatment outcome more than one year after
treatment.
Govind et al. (2003) studied 49 patients with occipital headaches who underwent percutaneous
radiofrequency neurotomy. Eighty-eight percent of the patients achieved a successful outcome
(complete relief of pain for at least 90 days). The median duration of relief in these patients was 297
days.
Occipital Neuralgia & Headache Page 12 of 21